Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
06 Feb 2026 03:20 PM
RNS
Form 8.3 - Oxford Biomedica plc
06 Feb 2026 09:52 AM
RNS
Form 8.5 (EPT/RI) - Oxford Biomedica plc
06 Feb 2026 07:00 AM
RNS
Rule 2.9 Announcement
05 Feb 2026 03:20 PM
RNS
Form 8.3 - Oxford Biomedica plc
05 Feb 2026 02:34 PM
RNS
Form 8.5 (EPT/RI) - Replacement of Oxford Biomedi
05 Feb 2026 02:21 PM
RNS
Form 8.3 Oxford Biomedica plc
05 Feb 2026 01:52 PM
RNS
Form 8.3 Oxford Biomedica plc
05 Feb 2026 10:46 AM
RNS
Form 8.5 (EPT/RI) - Oxford Biomedica plc
05 Feb 2026 10:41 AM
RNS
Form 8.5 (EPT/NON-RI) - Oxford Biomedica plc
05 Feb 2026 07:00 AM
RNS
Rule 2.9 Announcement
04 Feb 2026 03:20 PM
RNS
Form 8.3 - Oxford Biomedica plc
04 Feb 2026 10:41 AM
RNS
Form 8.5 (EPT/RI) - Oxford Biomedica plc
04 Feb 2026 10:38 AM
RNS
Form 8.5 (EPT/NON-RI) - Oxford Biomedica plc
04 Feb 2026 07:00 AM
RNS
Multi-year supply agreement with BMS
03 Feb 2026 12:19 PM
RNS
Form 8.3 - Oxford Biomedica PLC
03 Feb 2026 11:31 AM
RNS
Form 8.5 (EPT/NON-RI) Oxford Biomedica Plc
03 Feb 2026 07:55 AM
RNS
Form 8.5 (EPT/RI) - Oxford Biomedica plc
03 Feb 2026 07:48 AM
RNS
Form 8.5 (EPT/NON-RI) - Oxford Biomedica plc
02 Feb 2026 03:20 PM
RNS
Form 8.3 - Oxford Biomedica plc
02 Feb 2026 09:50 AM
RNS
Form 8.5 (EPT/RI) - Oxford Biomedica plc
02 Feb 2026 09:44 AM
RNS
Form 8.5 (EPT/NON-RI) - Oxford Biomedica plc
02 Feb 2026 07:00 AM
RNS
Total Voting Rights
30 Jan 2026 04:03 PM
RNS
Form 8.3 - Oxford Biomedica PLC
30 Jan 2026 03:20 PM
RNS
Form 8.3 - Oxford Biomedica plc
30 Jan 2026 02:49 PM
RNS
Form 8.3 - Oxford Biomedica PLC
30 Jan 2026 12:34 PM
RNS
Form 8.3 - Oxford Biomedica plc
30 Jan 2026 10:29 AM
RNS
Form 8.5 (EPT/RI) - Oxford Biomedica plc
30 Jan 2026 10:26 AM
RNS
Form 8.5 (EPT/NON-RI) - Oxford Biomedica plc
29 Jan 2026 03:20 PM
RNS
Form 8.3 - Oxford Biomedica plc
29 Jan 2026 03:14 PM
RNS
Form 8.3 - Oxford Biomedica PLC
29 Jan 2026 09:53 AM
RNS
Form 8.5 (EPT/RI) - Oxford Biomedica plc
29 Jan 2026 09:52 AM
RNS
Form 8.5 (EPT/NON-RI)-Oxford Biomedica plc
29 Jan 2026 07:00 AM
RNS
Rule 2.9 Announcement
28 Jan 2026 03:20 PM
RNS
Form 8.3 - Oxford Biomedica plc
28 Jan 2026 02:45 PM
RNS
Form 8.3 - Oxford Biomedica Plc
28 Jan 2026 02:25 PM
RNS
Form 8.3 - Oxford Biomedica plc
28 Jan 2026 12:08 PM
RNS
Form 8.3 - Oxford Biomedica PLC
28 Jan 2026 10:17 AM
RNS
Form 8.3 - Oxford Biomedica PLC
28 Jan 2026 09:30 AM
RNS
Form 8.5 (EPT/RI)- Oxford Biomedica plc
28 Jan 2026 09:29 AM
RNS
Form 8.5 (EPT/NON-RI)-Oxford Biomedica plc
27 Jan 2026 04:41 PM
RNS
Form 8.3 - Oxford Biomedica plc
27 Jan 2026 04:30 PM
RNS
Form 8.3 - Oxford Biomedica plc
27 Jan 2026 03:20 PM
RNS
Form 8.3 - Oxford Biomedica plc
27 Jan 2026 02:18 PM
RNS
Form 8.3
27 Jan 2026 02:07 PM
RNS
Form 8.3 - Oxford Biomedica plc
27 Jan 2026 01:29 PM
RNS
Form 8 - Oxford Biomedica plc
27 Jan 2026 11:12 AM
RNS
Form 8.5 (EPT/RI)-Replacement Oxford Biomedica plc
27 Jan 2026 11:12 AM
RNS
Form 8.5 (EPT/RI)-Replacement Oxford Biomedica plc
27 Jan 2026 11:02 AM
RNS
Form 8.3
27 Jan 2026 10:32 AM
RNS
Form 8.5 (EPT/NON-RI) Oxford Biomedica Plc

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings